Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$620K Hold
3,364
0.06% 201
2018
Q1
$572K Sell
3,364
-38
-1% -$6.97K 0.05% 210
2017
Q4
$590K Sell
3,402
-57
-2% -$10.1K 0.06% 201
2017
Q3
$644K Buy
3,459
+37
+1% +$6.56K 0.07% 192
2017
Q2
$589K Sell
3,422
-1,017
-23% -$165K 0.07% 198
2017
Q1
$728K Buy
4,439
+392
+10% +$65.1K 0.09% 186
2016
Q4
$591K Buy
+4,047
New +$609K 0.08% 198

Other funds holding AMGN

Edge Advisors's AMGN Position: Q2 2018 in Review

Edge Advisors held its Amgen (AMGN) position steady in Q2 2018 at 3,364 shares worth $620K. The position accounts for 0.06% of the portfolio, ranked #201.

Edge Advisors first reported a position in AMGN in Q4 2016 and has held it in 7 quarters since. The position peaked at $728K in Q1 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Edge Advisors held 3,364 shares of Amgen worth $620K as of Q2 2018.
  • Edge Advisors left its Amgen share count unchanged in Q2 2018.
  • Amgen made up 0.06% of Edge Advisors's portfolio in Q2 2018, its #201 holding.
  • Edge Advisors first reported a position in Amgen in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's Amgen position peaked at $728K in Q1 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.